EssilorLuxottica (OTCMKTS:ESLOY) Stock Price Down 7.8% – What’s Next?

EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY) shares were down 7.8% during mid-day trading on Tuesday . The stock traded as low as $140.93 and last traded at $141.3950. Approximately 225,897 shares traded hands during mid-day trading, an increase of 136% from the average daily volume of 95,598 shares. The stock had previously closed at $153.35.

Analyst Ratings Changes

A number of research analysts have weighed in on ESLOY shares. HSBC upgraded shares of EssilorLuxottica from a “hold” rating to a “buy” rating in a research report on Wednesday, January 14th. UBS Group upgraded EssilorLuxottica from a “hold” rating to a “strong-buy” rating in a research report on Thursday, November 27th. Zacks Research cut EssilorLuxottica from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, November 18th. Royal Bank Of Canada reiterated an “outperform” rating on shares of EssilorLuxottica in a research report on Tuesday, October 28th. Finally, The Goldman Sachs Group reissued a “buy” rating on shares of EssilorLuxottica in a research note on Friday, December 5th. Two investment analysts have rated the stock with a Strong Buy rating, five have issued a Buy rating and one has given a Hold rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Buy”.

EssilorLuxottica Stock Down 6.5%

The stock’s fifty day moving average price is $158.34 and its 200-day moving average price is $163.60. The company has a current ratio of 0.97, a quick ratio of 0.67 and a debt-to-equity ratio of 0.18.

About EssilorLuxottica

EssilorLuxottica SE is a global ophthalmic optics company formed through the 2018 merger of France-based Essilor and Italy-based Luxottica. Headquartered near Paris, the company combines lens manufacturing, frame design and production, brand management and retail operations to provide a vertically integrated offering across the vision care value chain. Its activities span product research and development, manufacturing, wholesale distribution and retailing of spectacles, sunglasses and ophthalmic lenses.

The company’s product portfolio includes prescription and non-prescription lenses, lens coatings and treatments, and an array of eyewear brands and frames.